Biomarkers usage in minimally invasive diagnosis of nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients

dc.contributor.authorBabak, Oleg
dc.contributor.authorMolodan, Volodymyr
dc.contributor.authorLapshyna, Kateryna
dc.contributor.authorProsolenko, Kostyantyn
dc.date.accessioned2017-12-04T07:09:31Z
dc.date.available2017-12-04T07:09:31Z
dc.date.issued2017
dc.description.abstractPlasma CK-18 and FGF-21 levels are increased in patients with NASH and also associate with atherogenic dyslipidemia and impaired liver enzyme activity. Study plasma levels of CK-18 and FGF21 allows to establish the presence of NASH in patients with NAFLD. The findings suggest the possibility of using these biomarkers for minimally invasive screening diagnosis of NASH and represent the perspective of further research.ru_RU
dc.identifier.citationBiomarkers usage in minimally invasive diagnosis of nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients /O. Y. Babak, V. I. Molodan, K. A. Lapshyna, K. O. Prosolenko // The New Armenian Medical Journal. – 2017. – Т. 11, № 2. – P. 46–51.ru_RU
dc.identifier.urihttps://repo.knmu.edu.ua/handle/123456789/18470
dc.language.isoen_USru_RU
dc.subjectNAFLDru_RU
dc.subjecthypertensionru_RU
dc.titleBiomarkers usage in minimally invasive diagnosis of nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patientsru_RU
dc.typeArticleru_RU

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
BioMARKERS.pdf
Size:
407.09 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
11.51 KB
Format:
Item-specific license agreed upon to submission
Description: